In This SectionTexas Health Research & Education Institute
Disease or Condition
Heart / Heart Failure
Post Market Survey for CRT or CT-D (Heart / Heart Failure)
The purpose of this study is to characterize the post market performance of the InSync defibrillator.
Patients implanted with an InSync Model 8040, InSync III Model 8042 or any Medtronic market released CRT-D system, a transvenous RV lead, and a Medtronic market released LV lead, as part of a system to deliver CRT therapy.
Patients must provide written informed consent and agree to be accessible for follow- up at the study center.
Patients with a history of a previously failed placement of an investigational Medtronic LV lead within 30 days of enrollment in the InSync Registry.
(Rationale: To minimize the possibility of implant related events for patients participating in ongoing Medtronic investigational LV lead studies being attributed to the study’s goals).